Skip to content
Screener

Penumbra PEN Q4 2025 Annual earnings

Reported February 25, 2026 · After market close

Revenue$385.4MBeat by $23.5M
EPS$1.18Beat by $0.07
Revenue estimate$361.9M
EPS estimate$1.11

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$401.4M
EPS estimate$1.20

Financials

Q4 2025

Income statement

See full
Revenue$385.4M+22.1%
Gross profit$262.1M+24.4%
Operating income$59.2M+38.5%
Net income$47.3M+40.6%
EPS (diluted)$1.20+37.9%

Balance sheet

See full
Cash & equivalents$186.9M-42.4%
Total debt$222.1M-1.6%
Total equity$1.4B+24.0%
Total assets$1.8B+19.1%

Cash flow

See full
Operating cash flow$86.5M+69.2%
CapEx$18.4M+243%
Free cash flow$68.1M+48.8%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$12.18B+33.6%
Enterprise value$12.21B+35.4%
P/E68.5×-582×
P/S8.7×+1.0×

Profitability

See full
Gross margin67.1%+3.9pp
Operating margin13.5%+12.7pp
Net margin12.7%+11.5pp
FCF margin12.5%+0.1pp

Returns & leverage

See full
Return on equity13.8%+12.6pp
Debt / equity0.2×0.0×
Current ratio6.6×+0.6×

Segments

By product

See full
Thrombectomy$254.7M+15.7%
Embolization and Other$113.9M+20.2%

FAQ

When did Penumbra report Q4 2025 earnings?
Penumbra (PEN) reported Q4 2025 earnings on February 25, 2026 after market close.
What were Penumbra's Q4 2025 revenue and EPS?
Penumbra reported revenue of $385.4M and eps of $1.18 for Q4 2025.
Did Penumbra beat estimates in Q4 2025?
Revenue beat the consensus estimate of $361.9M by $23.5M. EPS beat the consensus estimate of $1.11 by $0.07.
How did Penumbra's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 22.1% from $315.5M a year earlier and eps grew 21.6% from $0.97.
Where can I find Penumbra's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001321732-26-000006) and the 10-K periodic report (0001321732-26-000007) directly on SEC EDGAR. The filing index links above go to sec.gov.